Is Cigna (CI) a risky stock?
As of July 21, 2026, Clavix grades Cigna (CI) C- for risk, a composite score of 50 out of 100 on an A+ to F scale, which puts CI in the "average" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 21, 2026. Clavix regrades every trading day.
The five risk dimensions behind CI's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how CI scores on each, as of July 21, 2026.
What's moving CI's risk right now
Company-specific signals Clavix flags behind CI's current grade, drawn from recent news and filings as of July 21, 2026.
Cigna and Community Health Systems missed a contract deadline in their ongoing reimbursement standoff. If the dispute drags on, patients may shift to competitor hospitals and Cigna could face pressure if higher reimbursement rates are required.
A federal appeals court let providers' lawsuit accusing Cigna of underpaying out-of-network claims move forward, renewing legal exposure. Cigna could face damages or settlement costs and may have to change its reimbursement practices.
What a C- grade means
On the Clavix A+ to F scale, CI's composite of 50 falls in the C band (50–64), read as "average." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell CI or any security. Grades are risk indicators, not predictions of return. Data may be delayed.